Pembrolizumab for advanced melanoma not previously treated with ipilimumab

  • Technology appraisal guidance
  • TA366
  • Published: 
  • Last updated: 
Download guidance (PDF)

Update information

September 2017: Reference to a patient access scheme in section 1.1 has been replaced with details of a commercial access agreement. Sections 2.3 and 5.4 have been updated with the same information.

ISBN: 978-1-4731-1553-8